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Development of a post-mortem procedure to reduce the 
uncertainty regarding causes of death in developing countries
A major failure of our global society in the 21st century 
is that many people in developing countries are not 
only born and live without any oﬃ  cial record of their 
existence—a ﬂ agrant deprivation of an essential human 
right—but also die without having been seen by medically 
qualiﬁ ed personnel. The resultant uncertainty about the 
real burden of speciﬁ c causes of death is being increasingly 
recognised by international health and funding agencies 
as a crucial limitation in the prioritisation of eﬀ ective 
public health programmes and assessment of their eﬀ ect.1 
Recently published estimates of the main causes of global 
and cause-speciﬁ c mortality2,3 have stirred a profound 
debate about the validity and adequacy of existing 
methods used to estimate cause of death.4 
Complete diagnostic autopsies, indisputably the 
gold-standard method to estimate cause of death in 
developed countries,5 are undertaken infrequently in 
resource-poor settings. Reasons for this include the large 
proportion of deaths that occur outside the health system, 
insuﬃ  cient facilities or trained human resources,6 cultural 
or religious apprehension about the practice of post-
mortem procedures from the community perspective,7 
and decreasing consent rates in such regions. To bypass 
such problems, WHO now recommends the use of non-
invasive indirect methods such as the verbal autopsy,8 
a protocolised procedure that allows the classiﬁ cation 
of causes of death through analysis of data derived from 
structured interviews with family, friends, and caregivers. 
However, the Achilles’ heel of the verbal autopsy is its 
accuracy, which depends largely on the quality of the 
diagnostic criteria, the type of diseases involved, the 
location of death, and the delay between death and 
verbal autopsy. Deaths associated with non-speciﬁ c 
signs and symptoms are the most problematic,5 and are 
an especially common issue for perinatal and neonatal 
deaths. Despite these key limitations, verbal autopsies 
are the only source of data for cause of death in many 
settings, and their practice and improvement should 
therefore be encouraged. Assessment of the cause of 
in-hospital deaths is generally based on the clinician’s 
diagnosis of the disease(s) that led to the fatal outcome. 
However, such estimations are also prone to frequent 
misclassiﬁ cation errors. Indeed, when clinical diagnoses 
have been contrasted with post-mortem ﬁ ndings, rates 
of major clinical–pathological discrepancies have ranged 
from 10% to above 30%,9,10 especially in the diagnosis of 
infectious diseases. 
Thus, because the feasibility of routinely doing 
complete diagnostic autopsies is problematic, and 
indirect methods such as the verbal autopsy or clinical 
diagnosis are suboptimal, the development of feasible 
and more straightforward direct methods to ascertain the 
cause of death seems to be a priority. In recent years, the 
concept of minimally invasive autopsy as an alternative to 
classic complete diagnostic autopsy has been proposed. 
Minimally invasive autopsy includes the use of imaging 
techniques, such as MRI or CT scan, coupled with targeted 
small diagnostic biopsies (by needle puncture) of key 
organs. Although little experience has been gained with 
such techniques so far, they have been shown to produce 
reliable and comparable results to the complete diagnostic 
autopsy11–13 in developed countries. A further advantage of 
the method is the chance to improve our understanding 
of the pathogenesis of diseases that need human samples 
to be studied fully.
However, in its present form, minimally invasive autopsy 
is not a feasible technique in resource-poor settings. 
Thus, procedures to make minimally invasive autopsy 
feasible and acceptable in developing countries need 
to be deﬁ ned and standardised. These include the use 
of low-cost and portable imaging devices, the number 
of organs that need to be sampled, the preferred routes 
to obtain contamination-free tissue, and the speciﬁ c 
pathology and microbiology procedures that can provide 
relevant information related to the cause that underlies 
death. A consortium of African, American, Asian, and 
European institutions with expertise in clinical and 
socioanthropological research in low-income or middle-
income settings has been created with the aim to develop 
such a method. A validation exercise is being undertaken 
to compare the diagnostic reliability of a methodically 
predeﬁ ned minimally invasive autopsy device against 
the gold standard of complete diagnostic autopsy in two 
tertiary hospitals (in Maputo, Mozambique, and Manaus, 
Amazonas, Brazil), and to explore the potential use of 
classic and advanced microbiology techniques to further 
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investigate infectious causes of death in patients of any 
age. Such a minimally invasive autopsy device would 
need to balance out the best possible practices with the 
challenges of working in resource-poor settings, and also 
consider its future global applicability. In this respect, 
uncertainties related to the communities’ perception 
and acceptability of such a method, and the feasibility 
of actually implementing it in basic clinics or even in the 
community, needs to be explored rigorously. Social sciences 
research to complement the validation exercise has started 
in rural and urban areas in ﬁ ve countries (Mozambique, 
Gabon, Kenya, Mali, and Pakistan) and should provide 
the necessary answers and approaches for the future 
implementation of this method in resource-poor settings.
Conﬁ rmation that minimally invasive autopsy is a 
feasible, valid, and reliable method to inform about 
the cause of death could allow the introduction of such 
simpliﬁ ed techniques as an alternative to complete 
diagnostic autopsies or as a complement to verbal 
autopsy and clinical diagnosis. It would also strengthen 
the validity of contemporary and future models and 
cross-disease burden estimates, which are presently 
hampered by insuﬃ  cient inputs of raw data. Such a 
method could conceivably shed a clarifying light on 
one of the most fundamental, puzzling, and unresolved 
epidemiological questions: what do people die from in 
developing countries? 
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